Hyperammonemia increased the phosphorylation of p38 MAP kinase at T180/182, which was reversed by blocking S1PR2 (Figure 8a) or IL-1R (Figure 8b) or by inhibiting Src with PP2 (Figure 8c). Here, SRC is linked to Hyperammonemia.